An evidence gap map of digital health interventions for enhancing patient engagement in healthcare Authors: Usman Iqbal, Yankuba B. Manga, Dumisani Enricho Nkhoma, Afifa Tanweer, Syed Measum Haider Bokhari, Mochammad Fadjar Wibowo, Chih-Wei Huang, Anis Fuad, Rachael Smithson, Yi-Hsin Elsa Hsu, Robin Gauld, Nicholas Zwar, Julie Redfern, Leo Anthony Celi, Yu-Chuan Jack Li, Friedbert Kohler Published: 2026 ABSTRACT Digital health interventions (DHIs) are increasingly used to strengthen patient engagement. However, despite its rapid growth, DHIs remain unevenly evaluated and poorly standardized. Six databases were searched to generate an evidence gap map of interventions and research gaps for DHIs targeting patient engagement. A total of 160 systematic reviews (including 42 meta-analyses) comprising 3974 primary studies were mapped with most (92%) conducted in high-income countries. Evidence was concentrated around mHealth, eHealth, telehealth, and messaging technologies. Commonly reported outcomes included medication adherence, quality of life, implementation outcomes, and self-management. Overall, 61% of reviews reported positive conclusions, although most were rated as low or critically low methodological quality. Priority areas include strengthening evidence from LMICs, evaluating long-term and emerging DHIs (e.g., wearables and gamified platforms), and improving methodological rigor for systematic reviews. The findings highlight disparities in the global DHI evidence base and identify priority gaps for future research and implementation. Introduction Patient engagement denotes a collaborative process in which patients, caregivers, and healthcare professionals co-produce improvements in care1. Patient engagement is increasingly recognized as a core component of high-quality, patient-centered care. This was underscored by the World Health Organization’s 2023 World Patient Safety Day theme, Engaging Patients for Patient Safety, which emphasized patient engagement as essential to improving safety during the global shift toward patient-centered service delivery2. The Organization for Economic Co-operation and Development (OECD) reported that enhanced patient engagement is associated with a 15% reduction in harm in ambulatory care settings1,3. Patient engagement includes constructs, ranging from patient activation to medication adherence, which are broadly categorized either as behavioral, affective or cognitive4,5. It integrates dimensions such as health knowledge, behavior change, willingness to engage and self-management, enabling informed decision-making, proactive participation in care, leading to improved patient and system outcomes6,7. For example, recent studies report improvements in glycemic control and reductions in service use and costs associated with higher patient activation8,9 Digital health interventions (DHIs) have emerged as an important complement to clinical care, with growing evidence that they can strengthen patient engagement and amplify its impact7. For example, a meta-analysis of randomized controlled trials (RCTs) showed that mobile health (mHealth) interventions significantly improved medication adherence among patients compared to usual care10. Similarly, use of patient portals (ehealth) has been associated with increased patient activation and self-efficacy11,12. In this review, DHIs refer to technology-enabled tools supporting health care delivery or self-management, including mobile health (mHealth) applications, telehealth services, messaging systems, patient portals (eHealth), wearable devices, and digitally delivered behavioral or educational platforms13. mHealth is defined as mobile or app-based interventions delivered via smartphones or portable devices, while eHealth specifically refers to web-based platforms, patient portals, and online health services14. Despite rapid market growth, the digital health sector remains unevenly regulated and variably evaluated15,16. Although evidence continues to expand, many DHIs have not undergone rigorous evaluation through RCTs and other forms of evidence generation16,17. This creates challenges for adoption and scale-up of DHIs with high potential to improve patient engagement and system outcomes17. The sheer volume and heterogeneity of existing evidence also complicate translation into actionable policy18. There is therefore a need to synthesize existing evidence in formats that support evidence translation and align with global health priorities. Evidence Gap Maps (EGMs) use structured visual tools to systematically present the availability and characteristics of evidence on a particular topic. They display the quantity and quality of evidence across interventions and outcome domains19. In healthcare, EGMs have been increasingly adopted to synthesize and visualize complex and heterogeneous evidence bases, particularly where traditional systematic reviews may be too narrow to capture multidimensional interventions20–22. For this evidence gap map, patient engagement was conceptualized as a multidimensional construct encompassing behavioral, cognitive, and affective domains, which informed the categorization of outcomes across included reviews. This study aimed to generate a global evidence gap map of DHIs for enhancing patient engagement and to provide a structured overview of where evidence is concentrated or lacking. Specifically, we sought to systematically identify and classify relevant systematic reviews, map evidence across intervention and outcome domains, evaluate methodological quality and reported conclusions, and highlight priority gaps to guide future research, policy, and implementation of digital health–enabled patient engagement. Results We identified 7653 records across six databases of which 160 systematic reviews consisting of 3974 primary studies (135 reviews with randomized or non-randomized trials, 75 reviews with observational studies) were included. Figure 1 depicts the study selection and inclusion process. Qualitative evidence appeared in 42 reviews, and six reviews included other designs. Most primary studies were conducted in high-income countries (n = 3671), with the United States contributing the largest share (n = 1491), with limited representation from low- and middle-income countries (LMICs) (n = 302). Figure 2 depicts the geographical distribution of primary studies in the included reviews in the EGM.Fig. 1Search flow diagram.Flow diagram illustrating the number of records included and excluded at various screening and reviewing stages, and the final number of included reviews and studies. PICO, population, intervention, comparison and outcome.Fig. 2Global distribution of primary studies.Map depicting the number of primary included studies from each country. Search flow diagram. Flow diagram illustrating the number of records included and excluded at various screening and reviewing stages, and the final number of included reviews and studies. PICO, population, intervention, comparison and outcome. Global distribution of primary studies. Map depicting the number of primary included studies from each country. Distribution by conditions and medical domains Across domains, most reviews addressed medical conditions (k = 93,), followed by oncology (k = 18), mental health (k = 17), and smaller numbers in pediatric, physiotherapy, reproductive health, and dermatology domains. Figure 3 depicts the distribution of population by conditions aggregated into medical domains. Sixty-seven percent (k = 107) of the included reviews targeted adults exclusively and seven percent (k = 11) included children and adolescents.Fig. 3Distribution of studies across digital health interventions evaluated.Graph depicting study distribution by broad intervention categories. Distribution of studies across digital health interventions evaluated. Graph depicting study distribution by broad intervention categories. Distribution of studies by digital health intervention Included reviews evaluated a broad range of DHIs as depicted in Fig. 3. Interventions were categorized into telehealth (k = 85), mHealth (k = 99), eHealth (k = 106), messaging (k = 82), gamification (k = 15), social media (k = 15), and wearable or sensor technologies (k = 39). Telehealth interventions included teleconsultation (synchronous or asynchronous remote clinical follow-up) (k = 57), telerehabilitation (k = 11), and telemonitoring (k = 17). mHealth interventions included self-management apps (k = 75), symptom-tracking tools (k = 17), and lifestyle-focused applications (k = 7). Messaging interventions comprised text messaging (k = 55), interactive voice response systems (k = 13), and reminders (k = 14). eHealth interventions included patient portals (k = 31), interactive digital platforms (k = 61), and unidirectional educational websites (k = 14). Wearable technologies included external devices and ingestible sensors. Gamification interventions included gaming apps and virtual reality tools. Social media interventions included peer groups, blogs, forums, and online campaigns. Supplementary Fig. 1 shows the distribution of studies per intervention. The most frequently reported interventions were self-management apps (k = 27), online interactive platforms (k = 23), teleconsultations (k = 21), and text messaging (k = 19). Most DHIs were applied in internal medicine specialties (k = 92), followed by oncology (k = 19), mental health (k = 18) and surgical domains ((k = 18). Dermatology, reproductive health, and physiotherapy each accounted for ≤2% of interventions (see Supplementary Fig. 3). Most reviews reported studies with intervention duration of <12 months (60%), while only 11% reported studies with interventions lasting ≥12 months. Longer-duration interventions (≥12 months) were most observed in mHealth (k = 11), telehealth, messaging (k = 9), and eHealth (k = 8), and wearables or social media (k = 3). Overall, 61% of reviews reported positive conclusions for DHIs, 31% mixed findings, 4% unfavorable findings, and 4% did not report an overall conclusion. An overview of study characteristics is detailed in Supplementary Table 3. Distribution of reviews by study outcomes Patient engagement outcomes were analyzed separately from clinical and health system outcomes but mapped within a single framework. In general, the most reported outcomes were medication adherence (13%), quality of life (QoL) (11%), implementation outcomes (10%), self-management (10%), disease control (8%) and patient satisfaction (7%). The least reported outcomes were blood pressure, fatigue (1% each), anthropometric measurements, depression, distress, anxiety, risk reduction and cost evaluation (2% each). Across intervention–outcome combinations, most reviews reported positive conclusions (64%), followed by mixed (27%) and unfavorable (4%) findings (Supplementary Fig. 2). Figure 4 depicts the virtual network of interactions between interventions and outcomes included in this EGM. It has four levels of interactions denoted by the size of the bubble, ranging from high (biggest), moderate (medium-sized), low (smallest size) and least or no interaction (no bubble). The highest number of interactions was observed between eHealth, telehealth, mHealth and messaging interventions and medication adherence, QoL, disease control, patient satisfaction and implementation outcomes. Moderate levels of interaction were seen between gamification and implementation outcomes. Moderate level of evidence were also seen between gamification, social media, wearable interventions and service utilization and QoL and between anthropometric measurements, blood pressure, blood glucose and messaging and mHealth.Fig. 4Aggregate map of evidence gaps.Evidence gap map presenting an overview of evidence; the rows show the interventions, and the columns show the patient engagement level. The bubbles in each cell of the matrix depict the number of reviews categorized by quality assessment rating along. Aggregate map of evidence gaps. Evidence gap map presenting an overview of evidence; the rows show the interventions, and the columns show the patient engagement level. The bubbles in each cell of the matrix depict the number of reviews categorized by quality assessment rating along. Overall, gamification, wearable technologies, and social media interventions demonstrated the fewest mapped interactions across outcome domains. Similarly, outcomes such as blood pressure, fatigue, anxiety, depression, distress, risk reduction, cost-effectiveness, and symptom management were among the least represented across intervention categories. Discussion This evidence gap map provides a structured overview of how DHIs have been evaluated for enhancing patient engagement across clinical contexts. As an evidence gap map, the analysis did not examine causal pathways or interrelationships between outcomes. Digital health interventions and patient engagement operate within complex adaptive health systems, where contextual, organizational, and behavioral factors shape outcomes. Complexity-aware evaluation frameworks emphasize assessment across patient, service, and system levels, which may partly explain the heterogeneity observed across interventions and settings23. Several important domains remain under-represented. Interventions such as gamification and social media–based engagement were also limited. Likewise, minimal evidence addressed physiotherapy, neurological, pediatric, reproductive, or dermatological conditions. Affective patient engagement outcomes, including depression and anxiety, and secondary outcomes such as blood pressure, fatigue, and cost evaluation were sparsely reported. The predominance of low or critically low AMSTAR-2 ratings reflects recurring methodological challenges, including limited protocol registration, incomplete reporting of excluded studies, lack of funding transparency, and insufficient publication-bias assessment. Given that most reviews were rated as low or critically low quality, the mapped reported conclusions should be interpreted as indicative rather than confirmatory. Areas dominated by low-quality reviews may therefore represent priority targets for more rigorous primary and secondary research. This pattern aligns with broader analyses of digital health review quality22, which report inconsistent adherence to reporting standards. Although many reviews reported favorable engagement-related outcomes, confidence remains constrained by methodological limitations. Geographic distribution of evidence was profoundly imbalanced: only one in ten primary studies originated from low- and middle-income countries (LMICs), with sub-Saharan Africa especially underrepresented. This pattern mirrors global analyses documenting the persistent digital divide in health systems24 and limited DHI investment in LMICs25. Because many reviews reported positive conclusions across contexts, the absence of robust evidence from LMICs implies that potential benefits remain unrealized in regions with the greatest need, including regions with limited health workforce capacity where DHIs could supplement face-to-face services. Messaging and telehealth, among the least resource-intensive DHIs, hold promise for equitable adoption globally, consistent with prior reviews showing their cost-effectiveness and scalability26. The predominance of adult-focused studies reflects the epidemiology of chronic disease and the demographic distribution of digital health research. As such, children and adolescents were underrepresented despite being frequent users of digital technologies27. This gap may reflect ethical, regulatory, and practical constraints in conducting pediatric research, as well as limited availability of age-appropriate DHIs28. The concentration of evidence in diabetes, cardiovascular disease, cancers, and chronic respiratory diseases aligns with global noncommunicable disease burdens29. However, comparatively little evidence addressed major infectious and neurological conditions, indicating areas for future investigation. These gaps highlight priorities for future research. Strengths of this EGM include comprehensive coverage of systematic reviews and inclusion of methodological quality assessments. Quality appraisal and reported conclusions were extracted to enhance interpretability. However, several limitations should be considered. As an evidence gap map rather than a meta-analysis, it cannot determine causality or estimate pooled effect sizes. Reliance on published systematic reviews may underrepresent emerging primary evidence, particularly in rapidly evolving areas such as AI-enabled and wearable technologies. In addition, the predominance of low- or critically low-quality reviews limits certainty in mapped conclusions. Intervention duration presented another limitation as most DHIs were implemented in less than 12 months. Although many reviews included randomized or quasi-experimental studies that strengthen internal validity, the predominance of feasibility or pilot studies limits understanding of long-term sustainability. Prior meta-review emphasized the need for multi-year pragmatic trials assessing DHI durability30, particularly for chronic conditions where sustained engagement is essential. Across interventions, the most evidence-rich categories included disease self-management apps (17%), online interactive platforms (14%), teleconsultations (13%), and text messaging (12%). These reviews frequently reported improvements in medication adherence, disease control, QoL, and patient satisfaction. These findings are consistent with other large-scale DHI syntheses12,30. Telehealth, mHealth, eHealth, and messaging particularly for medication adherence, QoL, disease control, represent the most evidence-rich areas. Conversely, low-interaction domains such as social media, gamification, wearables, and cost-effectiveness represent both research gaps and missed opportunities. Despite widespread global use, social media interventions were rarely evaluated in high-quality patient engagement studies31. Gamification, a promising modality for behavioral and mental health engagement, similarly lacked rigorous evaluation32. Wearables showed minimal interaction with biometric outcomes such as blood pressure or anthropometric indicators, despite their technical suitability for continuous monitoring33. Cost-effectiveness evidence was particularly sparse, although essential for strategic purchasing and scale-up in health systems. Table 1 summarizes evidence takeaways and research gaps for consideration.Table 1Priority research, policy, and methodological recommendations for advancing digital health–enabled patient engagementResearch areaRecommendationHealth Policy; Digital Health EquityDesign strategies and roadmaps that promote easy assimilation of DHIs across all countriesResearch: Evidence gapsPromote environments favorable for digital health research and development across all settingsIncrease efforts to research application of DHIs in patient engagement for healthy aging especially in context of associated neurological conditions such as dementiaGenerate evidence for patient engagement through digital health means for chronic infectious diseases with global burdenTake advantage of the social media boom to create scientifically rigorous evidence of effectiveness for patient engagement and patient outcomes especially among adolescents and childrenConsider escalation of evidence generation for DHI-based patient engagement interventions for children and adolescents across all intervention and outcome spectraResearch: methodological considerationsFuture reviews should actively solicit funding data from primary studies, records protocols and present publication bias assessmentsFuture primary studies should move beyond feasibility and short-term outcomes to include longitudinal, cost-effectiveness, and implementation research Table 1Priority research, policy, and methodological recommendations for advancing digital health–enabled patient engagementResearch areaRecommendationHealth Policy; Digital Health EquityDesign strategies and roadmaps that promote easy assimilation of DHIs across all countriesResearch: Evidence gapsPromote environments favorable for digital health research and development across all settingsIncrease efforts to research application of DHIs in patient engagement for healthy aging especially in context of associated neurological conditions such as dementiaGenerate evidence for patient engagement through digital health means for chronic infectious diseases with global burdenTake advantage of the social media boom to create scientifically rigorous evidence of effectiveness for patient engagement and patient outcomes especially among adolescents and childrenConsider escalation of evidence generation for DHI-based patient engagement interventions for children and adolescents across all intervention and outcome spectraResearch: methodological considerationsFuture reviews should actively solicit funding data from primary studies, records protocols and present publication bias assessmentsFuture primary studies should move beyond feasibility and short-term outcomes to include longitudinal, cost-effectiveness, and implementation research Priority research, policy, and methodological recommendations for advancing digital health–enabled patient engagement As DHIs diversify, robust multi-stage evaluation frameworks will be essential to support safe integration into clinical systems. Context-sensitive evaluation approaches may accelerate uptake of emerging technologies into routine care34,35. As health systems face increasing resource constraints, rigorous and equity-oriented digital health research will be essential to ensure that the benefits of technology-enabled patient engagement extend to all populations33. Findings from the EGM offer actionable insights for policymakers, researchers, and implementers. At the same time, substantial evidence gaps demand targeted investment. Further research should prioritize long-term and context-sensitive evaluations of emerging DHIs, including AI-enabled interventions, gamification, social media, and wearable technologies. Greater emphasis on cost-effectiveness, implementation science, and staged evaluation frameworks will be essential to support sustainable and equitable adoption of digital health–enabled patient engagement. Methods The evidence gap map was conducted in accordance with the Campbell Collaboration guidelines for evidence gap maps21. and followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards36, with the protocol registered in the International Prospective Register of Systematic Reviews (PROSPERO; CRD42024575453). The review followed a Population–Intervention–Outcome (PICO-informed) framework. The population included patients of any age or condition; interventions comprised DHIs designed to enhance patient engagement; and outcomes included patient engagement (behavioral, cognitive, and affective), with patient health and health system outcomes treated as secondary domains. Ethical approval was not required as this study analyzed published data. Criteria for considering reviews for inclusion Only systematic reviews published between 2015 and 2025 that reported DHIs and patient engagement outcomes as either a primary or secondary outcome were selected. The EGM excluded reviews that did not use systematic review methodology; outside the scope of DHIs or patient engagement; primary studies and non-systematic publications (e.g., abstracts and commentaries); or that lacked accessible full text or English-language availability. No population restrictions were applied. Search methods and identification of reviews Searches were conducted in July 2024 and updated in July 2025 in the following six databases: Cochrane Library, PubMed, Web of Science, Scopus, EMBASE and EBSCOHOST, including all records indexed up to 30 June 2025, with no language restrictions. The search strategy combined MeSH terms and free-text keywords for digital health (“digital health”, “mHealth”, “eHealth”, “telehealth”, telemedicine”, “online intervention”, “internet intervention”, “digital intervention*”) and patient engagement (“patient engagement”, “patient participation”, “patient involvement” “patient empowerment”, “patient activation”, “self-management”, “adherence”, “patient satisfaction”), combined with review identifiers (“systematic review”, “meta-analysis”). Full database-specific strategies are provided in the Supplementary Pages 16–23. All citations were imported into Endnote37 for de-duplication and screening. Screening was conducted in two stages. Two reviewers (YM and AT) independently screened titles and abstracts and subsequently assessed full texts for eligibility. They resolved disagreements through discussion or, when required, consultation with a third reviewer (AF). Data collection A standardized extraction form was developed to capture publication characteristics, intervention type, delivery modality, target population, patient engagement domains, findings and limitations. Each review was coded using a pre-specified analytical framework that categorized DHIs into intervention groups and patient engagement constructs. Intervention and outcome categories were defined a priori through team consensus. Where interventions overlapped (for example, self-management apps incorporating messaging or monitoring functions), classification was based on the primary modality described by review authors. Patient engagement constructs (including activation, adherence, self-management, satisfaction, and emotional engagement) were mapped to behavioral, cognitive, or affective domains using predefined definitions4,5. Coding disagreements and classification uncertainties were resolved through discussion and, where required, consultation with a senior reviewer. To maintain consistency, messaging interventions referred to structured reminders or communication systems (e.g., SMS), whereas social media interventions involved interactive peer or community platforms. Telehealth included synchronous or asynchronous remote clinical care, and remote monitoring technologies were classified under telehealth or wearable categories based on primary functionality described in each review. Data collected included participant characteristics, study location, intervention duration, and review-level conclusions and quality ratings. For DHIs the following categories were defined; mobile health, telehealth platforms, eHealth portals, messaging, social media and wearable technologies. A detailed breakdown is provided under Table 2. Patient engagement outcomes were categorized into behavioral, affective, and cognitive domains. Clinical (patient health) outcomes and health system outcomes were treated as secondary outcome domains and mapped separately from patient engagement constructs. Behavioral outcomes consisted of patient self-management, physical activity, medication adherence, non-pharmacological adherence and risk reduction5,38. Cognitive outcomes primarily reflected health knowledge4. Patient satisfaction, activation, depression, anxiety, well-being and distress were categorized as affective. For patient health outcomes, the EGM summarized the following outcomes, disease control, symptom management, blood glucose, blood pressure, anthropometric measurements, fatigue and QoL. Blood pressure and blood glucose were analyzed separately from broader disease-control outcomes when explicitly reported. Health system outcomes included health services utilization, cost evaluation and implementation outcomes such as feasibility, acceptability, user engagement or intervention adoption. All DHIs and outcome definitions are listed under Supplementary Table 1.Table 2Summary of characteristics of included reviewsCategoryInterventions categoriesOutcome categoriesTelehealthmHealthMessagingeHealthWearablesSocial mediaGamificationBehavioralCognitiveAffectivePatient HealthHealth SystemsStudiesNo. of Reviews (k)709166953415149915469169No. of Included Studies(n)155124521585219711033442582416419103921831927NR200000010010Population (Geographical Location)HICs2081492681992127015035615031735776LMICs6666847782163112267941327Age categoryAdults486942671978697346047Children3458323732104Mixed131618201263235102118NR (Age)321010010010Timing (Year)Before 2020314230421575494194424After 20203949365320895111274845Intervention duration<12 months36534557201013598295727>12 months811983301312125Varying262714301221286152337Designs includedExperimental588064822615128813368453Observational354327392075448203741Qualitative162211251446255181925Other311230040023Reported overall conclusionStrong484801070372Positive38513448211085810265541Mixed252522271236263142519Unfavorable055511061152N/A321710031205AMSTAR-2 ratingHigh000000000000Moderate010000000010Low344236441394498164419Critically Low3648305122610517304750Interventions and outcomes are defined in Supplementary Table 1. Below is the list of interventions found; Telehealth: Teleconsultations Telerehabilitation, Tele palliative care, Telemonitoring, mHealth: Symptom trackers, Self-management/apps, Lifestyle apps, Messaging: SMS texts, WhatsApp bots, Tailored/theory based texts, eHealth: Online portals, Electronic health records, Online interactive platforms, Online cognitive-based therapies (CBTs), Online peer forums, Online Socio-Behavioral Change (SBC) programs, Online unidirectional educational resources, Wearables; Ingestible sensors, Electronic inhaler monitoring devices, Fitbits, Pedometers, Accelerometers, Smart bands, GPS / Bluetooth trackers, Social Media: Blogs, Forums, Chat lines, Gamification: Gamified apps, Rewards/Contingency management, Virtual reality.HICS high income countries (in this review, upper middle class were included in this category), LMICs low and lower middle-income countries, N/A not applicable, NR not reported, n number of primary studies within included reviews, k number of included reviews. Table 2Summary of characteristics of included reviewsCategoryInterventions categoriesOutcome categoriesTelehealthmHealthMessagingeHealthWearablesSocial mediaGamificationBehavioralCognitiveAffectivePatient HealthHealth SystemsStudiesNo. of Reviews (k)709166953415149915469169No. of Included Studies(n)155124521585219711033442582416419103921831927NR200000010010Population (Geographical Location)HICs2081492681992127015035615031735776LMICs6666847782163112267941327Age categoryAdults486942671978697346047Children3458323732104Mixed131618201263235102118NR (Age)321010010010Timing (Year)Before 2020314230421575494194424After 20203949365320895111274845Intervention duration<12 months36534557201013598295727>12 months811983301312125Varying262714301221286152337Designs includedExperimental588064822615128813368453Observational354327392075448203741Qualitative162211251446255181925Other311230040023Reported overall conclusionStrong484801070372Positive38513448211085810265541Mixed252522271236263142519Unfavorable055511061152N/A321710031205AMSTAR-2 ratingHigh000000000000Moderate010000000010Low344236441394498164419Critically Low3648305122610517304750Interventions and outcomes are defined in Supplementary Table 1. Below is the list of interventions found; Telehealth: Teleconsultations Telerehabilitation, Tele palliative care, Telemonitoring, mHealth: Symptom trackers, Self-management/apps, Lifestyle apps, Messaging: SMS texts, WhatsApp bots, Tailored/theory based texts, eHealth: Online portals, Electronic health records, Online interactive platforms, Online cognitive-based therapies (CBTs), Online peer forums, Online Socio-Behavioral Change (SBC) programs, Online unidirectional educational resources, Wearables; Ingestible sensors, Electronic inhaler monitoring devices, Fitbits, Pedometers, Accelerometers, Smart bands, GPS / Bluetooth trackers, Social Media: Blogs, Forums, Chat lines, Gamification: Gamified apps, Rewards/Contingency management, Virtual reality.HICS high income countries (in this review, upper middle class were included in this category), LMICs low and lower middle-income countries, N/A not applicable, NR not reported, n number of primary studies within included reviews, k number of included reviews. Summary of characteristics of included reviews Interventions and outcomes are defined in Supplementary Table 1. Below is the list of interventions found; Telehealth: Teleconsultations Telerehabilitation, Tele palliative care, Telemonitoring, mHealth: Symptom trackers, Self-management/apps, Lifestyle apps, Messaging: SMS texts, WhatsApp bots, Tailored/theory based texts, eHealth: Online portals, Electronic health records, Online interactive platforms, Online cognitive-based therapies (CBTs), Online peer forums, Online Socio-Behavioral Change (SBC) programs, Online unidirectional educational resources, Wearables; Ingestible sensors, Electronic inhaler monitoring devices, Fitbits, Pedometers, Accelerometers, Smart bands, GPS / Bluetooth trackers, Social Media: Blogs, Forums, Chat lines, Gamification: Gamified apps, Rewards/Contingency management, Virtual reality. HICS high income countries (in this review, upper middle class were included in this category), LMICs low and lower middle-income countries, N/A not applicable, NR not reported, n number of primary studies within included reviews, k number of included reviews. For each included review, we recorded the overall conclusions as reported by the review authors (positive, mixed, unfavorable or not reported). Because many reviews relied on narrative synthesis rather than pooled meta-analysis, these categories reflect review authors’ overall interpretations rather than standardized statistical significance across reviews. Outcome data were synthesized descriptively across reviews and mapped to predefined intervention and outcome categories to facilitate structured comparison across domains. Quality assessment The methodological rigor of all included reviews was assessed using the AMSTAR-2 tool39. Two reviewers (AT and DEN) conducted independent appraisals and resolved discrepancies through consensus. Key AMSTAR-2 domains included protocol registration, justification of study exclusions, reporting of funding sources, and evaluation of publication bias (Supplementary Table 2). AMSTAR-2 ratings were used to contextualize interpretation of review conclusions. Findings from reviews rated as low or critically low quality were interpreted cautiously and were not considered equivalent to those from higher-quality reviews. Disagreements between reviewers were resolved through discussion and, where required, consultation with a third reviewer to ensure consistency in ratings. Analysis Data was synthesized descriptively and organized into a two-dimensional matrix mapping intervention categories against outcome domains. Bubble plots were generated to visualize the volume, distribution and methodological quality of evidence, with bubble size reflecting the number of included primary studies and color indicating AMSTAR-2 ratings. Visualizations were generated using custom scripts developed in Python (3.13.5)40. Statistics and reproducibility To support reproducibility, all database-specific search strategies and their search dates are reported. Supplementary information Supplemental Material Supplemental Material